Angewandte Chemie International Edition · 2014 · 16 citations · 38 references
Natural SciencesChemistryMedicinal ChemistryCancer PharmacologyDrug DiscoveryOrganometallic ChemistryAlkyne ComplexesCoordination ChemistryLigand BindingTargeting LigandsAlkyne Cycloaddition ReactionsAlkyne Platinum ComplexesAzide-alkyne Cycloaddition ProbesBondingClick Chemistry FunctionalizationClick-chemistry LinkersConjugationPlatinum Compounds
To better understand the range of cellular interactions of Pt(II) -based chemotherapeutics, robust and efficient methods to track and analyze Pt targets are needed. A powerful approach is to functionalize Pt(II) compounds with alkyne or azide moieties for post-treatment conjugation through the azide-alkyne cycloaddition (click) reaction. Herein, we report an alkyne-appended cis-diamine Pt(II) compound, cis-[Pt(2-(5-hexynyl)amido-1,3-propanediamine)Cl2] (1), the X-ray crystal structure of which exhibits a combination of unusual radially distributed CH/π(C≡C) interactions, Pt-Pt bonding, and NH:O/NH:Cl hydrogen bonds. In solution, 1 exhibits no Pt-alkyne interactions and binds readily to DNA. Subsequent click reactivity with nonfluorescent dansyl azide results in a 70-fold fluorescence increase. This result demonstrates the potential for this new class of alkyne-modified Pt compound for the comprehensive detection and isolation of Pt-bound biomolecules.
38
CH/? hydrogen bonds in crystals
Motohiro Nishio · CrystEngComm · 2004 · 1.4K citations
Cisplatin and platinum drugs at the molecular level (Review)
Teni Boulikas, Maria Vougiouka · Oncology Reports · 2003 · 728 citations
Medicine, Oncology, Pharmacology +14
Clinical and pharmacological studies with cis-diamminedichloroplatinum (II).
Ronald C. DeConti, Bartlett R. Toftness, Robert Lange et al. · PubMed · 1973 · 427 citations
Pharmacy, Pharmacology, Toxicology +10